GigaGen
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
407 Cabot Rd, South San Francisco, Calif...Phone Number
(415) 978-2101Website
www.gigagen.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About GigaGen
GigaGen is a biopharmaceutical company based in San Carlos, California, specializing in antibody drug discovery using advanced single-cell technologies. The company focuses on developing novel recombinant polyclonal and monoclonal antibody therapies for immunodeficiencies, infectious diseases, and cancers, with a commitment to revolutionizing treatment options. GigaGen's innovative platforms enable the recreation of complete immune repertoires, leading to the creation of highly potent antibody drugs, including its lead oncology asset, GIGA-564. The company aims to address life-threatening diseases by leveraging its proprietary technology to discover and develop transformative antibody therapies.Explore more
GigaGen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GigaGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if GigaGen is spiking on competitors!
Check if GigaGen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at GigaGen
Earning: See what the market has to say on GigaGen recently announced quarterly report
Funding: Get notified immidiatlly once GigaGen has new funding data
Product Launch: Get notified when GigaGen launches new products
Click to see if GigaGen had a recent Job posting/layoffs
GigaGen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to GigaGen
Compare insights from companies similar to GigaGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GigaGen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GigaGen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GigaGen.
GigaGen financials insights
Gather financial insights about GigaGen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$36.1M
2020
Debt
$350K
GigaGen Tech Stack
A closer look at the technologies used by GigaGen
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Research & Development, Product Management, Legal Affairs, Governmental Affairs & Regulation, Medical Research, Pharmaceuticals, Clinical Operations
Project
A mid-level source has indicated that the largest upcoming initiative is an IT overhaul and the organization will focus on an enterprise resource planning (ERP) integration to support these initiatives.
Integration, Enterprise Software
Project
Implementation, Contingent Workforce, Business Development, Enterprise Software, Operating Systems
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GigaGen
Sign Up For FreeTo access detailed company insights
GigaGen is a biopharmaceutical company based in San Carlos, California, specializing in antibody drug discovery using advanced single-cell technologies. The company focuses on developing novel recombinant polyclonal and monoclonal antibody therapies for immunodeficiencies, infectious diseases, and cancers, with a commitment to revolutionizing treat... Read More
